Gemcitabine, used alone or in combination with other chemotherapy agents, seems to improve the quality of life for patients with pancreatic cancer. Chemotherapy with gemcitabine improves symptoms, including pain, nausea, and vomiting in about 25% of patients. It also provides a modest increase in survival (usually only a few months).
Fluorouracil is not associated with a survival benefit. Cisplatin and some other drugs have been used in combination with gemcitabine, but are associated with more side effects.
These drugs should be used with caution in the elderly and those with liver or
. Elderly patients are at an increased risk of side effects.